CIPLANSECipla Limited· PharmaceuticalsHighNeutral
Announced Tue, 13 May · 13:56 IST

Cipla Limited has informed the Exchange regarding Outcome of Board Meeting held on May 13, 2025.

Pat Growth 25pctExceptional ItemResults View source PDF

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Cipla's Board approved audited consolidated results for FY25 with revenue from operations at Rs 27,547.62 crores, up about 6.9% from Rs 25,774.09 crores in FY24. Net profit jumped to Rs 5,269.20 crores versus Rs 4,153.72 crores, a growth of roughly 27%, translating to EPS of Rs 65.29 (vs Rs 51.05). Q4 FY25 was strong with revenue of Rs 6,729.69 crores and net profit of Rs 1,214.14 crores, up about 30% year-on-year. The Board recommended a final dividend of Rs 13 per share plus a special dividend of Rs 3 per share to mark Cipla's 90th anniversary, taking the total to Rs 16 per share, with a record date of June 27, 2025. The statutory auditor (Walker Chandiok & Co LLP) issued an unmodified opinion on the results.

Likely market impact

Solid double-digit profit growth and a generous total dividend (Rs 16/share, including a one-time special dividend) are positive for shareholders and likely supportive of the stock in the near term, though revenue growth was single-digit.